AlphaYou
Overview
Smart money at a glance
Filings to Oct 4, 2026Net selling: insiders sold $1.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$1.3M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 0 added, 1 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 4- Open
- $23.72
- 52-wk high
- $28.23
- High
- $23.75
- 52-wk low
- $9.00
- Low
- $22.85
- Prev close
- $23.34
- Mkt cap
- $2.39B
- Volume
- 814.8K
- Beta
- 1.80
- P/S
- 64.9x
- P/B
- 6.2x
- Profit margin
- +0.0%
- Op margin
- -1042.0%
- ROE
- -80.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about NRIX filings
Are insiders buying or selling Nurix Therapeutics Inc (NRIX) stock?
Net selling: insiders sold $1.3M and bought $0 of NRIX stock on the open market in the 90 days to Oct 4, 2026, according to SEC Form 4 filings. $1M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Ring, Christine (Chief Legal Officer), who sold $756K. The latest filing was on Oct 2, 2026.
Which members of Congress have traded NRIX recently?
None. No member of Congress disclosed a NRIX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this NRIX smart-money data?
This summary uses filings available on Oct 4, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Sells/Trims (1)
- P7
Point72
$54.0M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in NRIX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 11.0% below what analysts expected.
Last report
Jul 9, 2026
Period ending
May 31, 2026
Earnings per share
-$0.73 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| May 31, 2026 | Jul 9, 2026 | -$0.81 / -$0.73Alpha Vantage | -10.96% miss | Unavailable | Unavailable |
| Feb 28, 2026 | Apr 8, 2026 | -$0.79 / -$0.83Alpha Vantage | +4.76% beat | Unavailable | Unavailable |
| Nov 30, 2025 | Jan 28, 2026 | -$0.82 / -$0.92Alpha Vantage | +10.87% beat | Unavailable | Unavailable |
| Aug 31, 2025 | Oct 9, 2025 | -$1.03 / -$0.85Alpha Vantage | -21.18% miss | Unavailable | Unavailable |
| May 31, 2025 | Jul 9, 2025 | -$0.52 / -$0.74Alpha Vantage | +29.73% beat | Unavailable | Unavailable |
| Feb 28, 2025 | Apr 8, 2025 | -$0.67 / -$0.76Alpha Vantage | +11.84% beat | Unavailable | Unavailable |
| Nov 30, 2024 | Jan 28, 2025 | -$0.75 / -$0.67Alpha Vantage | -12.12% miss | Unavailable | Unavailable |
| Aug 31, 2024 | Oct 11, 2024 | -$0.67 / -$0.68Alpha Vantage | +1.47% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 8, 2026, in 4 days
Financials
What it sold, what it cost, what was left.
| USD | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.9M | $13.6M | $6.3M | $9.0M |
| Cost of what it sold | $5.0M | $4.6M | $84.1M | $3.9M |
| Gross profit | $2.9M | $8.9M | -$77.9M | $5.2M |
| What it spent | ||||
| Research and development | $86.1M | $80.9M | $84.1M | $87.7M |
| Sales and admin | $13.2M | $13.6M | $14.6M | $15.6M |
| Other operating costs | -$5.0M | -$2.5M | -$84.1M | -$3.9M |
| Total operating expenses | $94.3M | $92.0M | $14.6M | $99.4M |
| What was left | ||||
| Operating profit | -$91.4M | -$83.1M | -$92.5M | -$94.2M |
| Profit before tax | -$86.4M | -$78.2M | -$87.2M | -$89.8M |
| Tax | — | — | — | -$271.0K |
| Net profit | -$86.4M | -$78.2M | -$87.2M | -$89.5M |
| EBITDA | -$81.4M | -$69.0M | -$83.4M | -$86.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace